SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001062993-24-003481
Filing Date
2024-02-16
Accepted
2024-02-16 17:15:16
Documents
2
Period of Report
2024-02-14

Document Format Files

Seq Description Document Type Size
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.html 3  
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.xml 3 1525
2 POWER OF ATTORNEY exhibit24-1.htm EX-24.1 9571
  Complete submission text file 0001062993-24-003481.txt   12724
Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Issuer) CIK: 0001860871 (see all company filings)

IRS No.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O TEVOGEN BIO HOLDINGS INC. 15 INDEPENDENCE BOULEVARD WARREN NJ 07059
Business Address
Patton Curtis L. (Reporting) CIK: 0002011753 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41002 | Film No.: 24649502